GPP
GPP is a rare, chronic, systemic, autoimmune disease which is potentially life threatening if left untreated. It is characterized by flares which appear in the form of a widespread eruption of painful pustules over large areas of the body, along with redness, severe itch, and dry, cracked, or scaly skin. It can be accompanied by more general symptoms, such as fever, headache, extreme tiredness or a burning sensation on the skin. To learn more about GPP read more (link to GPP infographic) or visit GPPandME and GPPWalksIn. Below you will find resources to learn more about GPP.
Latest Article
GPP
Generalized pustular psoriasis: The value of collaboration
Dr Emmanuelle Clerisme-Beaty, Boehringer Ingelheim’s Therapeutic Area Inflammation Head of Medicine, in conversation with Dr Bruce Strober MD, PhD
GPP
Generalized pustular psoriasis: Unmet needs
Dr Emmanuelle Clerisme-Beaty, Boehringer Ingelheim’s Therapeutic Area Inflammation Head of Medicine, in conversation with Dr Bruce Strober MD, PhD
GPP
Generalized pustular psoriasis (GPP): a rare, chronic, systemic disease
A rare, chronic, systemic autoinflammatory disease that can be life-threatening if left untreated.
Links
Read more
Opens in new tabGPP
GPPandMe
Understand your condition through our dedicated generalized pustular psoriasis (GPP) resources
Read more
Opens in new tabGPP
GPP Walks In
Our site for healthcare professionals to find out more about the impact of generalized pustular psoriasis (GPP)
Downloads
Interleukin-36 (IL-36) pathway
The IL-36 pathway and pustular psoriasis
Generalized Pustular Psoriasis (GPP)
Facts about a rare and chronic autoinflammatory skin disease
Unmet needs in GPP
Learn more about the unmet needs of people living with GPP and how multi-level support can be implemented to improve the lives patients.
Live well with Generalized Pustular Psoriasis
New insights from people living with generalized pustular psoriasis (GPP)
Related Press Releases
March 19, 2024
SPEVIGO® approved for expanded indications in China and the US
October 30, 2023